ABC | Volume 114, Nº5, May 2020

Viewpoint Nascimento et al. Anticoagulation in severe COVID-19 Arq Bras Cardiol. 2020; 114(5):829-833 This is an open-access article distributed under the terms of the Creative Commons Attribution License 19. Yao Xiaohong, Li Tingyuan, He Zhicheng, Coronavirus disease pneumonia 2019 (COVID-19): 3 cases of puncture histopathology in several locations. Chin J Pathol. 2020,49. 20. Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical Pathology of Critical Patient with Novel Coronavirus Pneumonia (COVID-19). Preprints. 2020, 2020020407. 21. Agência Fapesp. Autópsia emmortos por COVID-19 ajuda no tratamento de casos graves da doença. [Acesso em04 abr 2020] Disponível em:<http:// agencia.fapesp.br/autopsia-em-mortos-por-covid-19-ajuda-no-tratamento- de-casos-graves-da-doenca/32882/> 22. ChenN, ZhouM, Dong X, Qu J, Gong F, Han Y, Qiu Y,Wang J, Liu Y,Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia inWuhan, China: a descriptive study. Lancet. 2020;395(10223):507. Epub 2020 Jan 30. 23. Zhang Y, Cao W, Xiao M, Li YJ, Yang Y, Zhao J, Zhou X, Jiang W, Zhao YQ, Zhang SY, Li TS. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 28;41(0):E006. 24. Taisheng Li, Hongzhou Lu, Wenhong Zhang. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020 Dec;9(1):687-90. 25. Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017; 149:38–44. 26. Schmitt FCF, Manolov V, Morgenstern J, Fleming T, Heitmeier S, Ubile F, et al.Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care. 2019; 9(1):19. 27. Iba T, Levy JH, Warkentin TE, Tachill J, van der Poll T. Diagnosis and managementofsepsis-inducedcoagulopathyanddisseminated intravascular coagulation. J Thromb Haemost. 2019; 17(11):1989–94. 28. IbaT,NisioMD,LevyJH,KitamuraN,ThachilJ.Newcriteriaforsepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017; 7(9):e017046. 29. Levi AM, van der Poll HR.. Buller, The bidirectional relationship between coagulation and inflammation, Circulation.2004;109(22):2698-704. 30. ZimmermanBGA,McIntyreTM,PrescottSM,StafforiniS.Theplatelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit CareMed. 2002; 30(Suppl):S294-S301. 31. ShebuskiCRJ,KilgoreKS.Roleof inflammatorymediators inthrombogenesis. J Pharmacol Exp Ther. 2002;300(3):729-35. 32. Levi DM, van der Poll T. Coagulation in patients with severe sepsis. Semin. Thromb. Hemost.2015;41(1):9-15. 33. SingerM,DeutschmanCS,SeymourCW,Shankar-HariM,AnnaneD,BauerM, etal.TheThirdInternationalConsensusDefinitionsforSepsisandSepticShock (Sepsis-3). JAMA. 2016;315(8):801-10. 34. Tang N, Li D,Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020.18(4):844-7. 35. GuptaN,ZhaoYY,EvansCE.Thestimulationofthrombosisbyhypoxia.Thromb Res.2019;181:77–83. 36. TangN,BaiH,ChenX,GongJ,LiD,SunZ.Anticoagulanttreatmentisassociated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.J Thromb Haemost. 2020 Mar 27 (online ahead of print). Accepted Author Manuscript. doi:10.1111/jth.14817. 37. World Health Organization (WHO). Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interimguidance. [Cited in 06Apr 2020] Available from: <https://www.who . int/publications-detai>. 38. National HealthCommissionofChina.Thediagnosisandtreatmentplanforthe novelcoronavirusdisease7thed.;2020.[Citedin2020 06Apr]Availablefrom: <https://www.chinalawtranslate.com/en/coronavirus-treatment-plan-7/ >. 833